RPG Life Sciences Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares RPG Life Sciences Limited with three other
pharmaceutical manufacturers in Asia:
Reprocell Inc
of Japan
(2019
sales of 1.09 billion Japanese Yen [US$9.93 million]
),
Kopran Limited
(3.58 billion Indian Rupees [US$50.97 million]
), and
Fervent Synergies Limited
(166.67 million Indian Rupees [US$2.37 million]
).
Sales Analysis.
RPG Life Sciences Limited reported sales of 3.30 billion Indian Rupees (US$47.01 million)
for the
fiscal
year ending
March of 2019.
This
represents
a
decrease of 4.0%
versus 2018, when the company's sales were 3.44 billion Indian Rupees.